Global Neoantigen Targeted Therapies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 279719
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Neoantigen Targeted Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Neoantigen Targeted Therapies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medical Research Institution accounting for % of the Neoantigen Targeted Therapies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monotherapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Neoantigen Targeted Therapies include Bavarian Nordic, Genocea Biosciences, Gradalis, Immunicum, and Immunovative Therapies, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Neoantigen Targeted Therapies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Monotherapy

Combination Therapy

Market segment by Application, can be divided into

Medical Research Institution

Hospital and Clinic

Other

Market segment by players, this report covers

Bavarian Nordic

Genocea Biosciences

Gradalis

Immunicum

Immunovative Therapies

Iovance Biotherapeutics

MediGene

Neon Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Neoantigen Targeted Therapies product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Neoantigen Targeted Therapies, with revenue, gross margin and global market share of Neoantigen Targeted Therapies from 2019 to 2022.

Chapter 3, the Neoantigen Targeted Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Neoantigen Targeted Therapies market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Neoantigen Targeted Therapies research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Neoantigen Targeted Therapies

1.2 Classification of Neoantigen Targeted Therapies by Type

1.2.1 Overview: Global Neoantigen Targeted Therapies Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Neoantigen Targeted Therapies Revenue Market Share by Type in 2021

1.2.3 Monotherapy

1.2.4 Combination Therapy

1.3 Global Neoantigen Targeted Therapies Market by Application

1.3.1 Overview: Global Neoantigen Targeted Therapies Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Medical Research Institution

1.3.3 Hospital and Clinic

1.3.4 Other

1.4 Global Neoantigen Targeted Therapies Market Size & Forecast

1.5 Global Neoantigen Targeted Therapies Market Size and Forecast by Region

1.5.1 Global Neoantigen Targeted Therapies Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Neoantigen Targeted Therapies Market Size by Region, (2017-2022)

1.5.3 North America Neoantigen Targeted Therapies Market Size and Prospect (2017-2028)

1.5.4 Europe Neoantigen Targeted Therapies Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Neoantigen Targeted Therapies Market Size and Prospect (2017-2028)

1.5.6 South America Neoantigen Targeted Therapies Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Neoantigen Targeted Therapies Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Neoantigen Targeted Therapies Market Drivers

1.6.2 Neoantigen Targeted Therapies Market Restraints

1.6.3 Neoantigen Targeted Therapies Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Bavarian Nordic

2.1.1 Bavarian Nordic Details

2.1.2 Bavarian Nordic Major Business

2.1.3 Bavarian Nordic Neoantigen Targeted Therapies Product and Solutions

2.1.4 Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Bavarian Nordic Recent Developments and Future Plans

2.2 Genocea Biosciences

2.2.1 Genocea Biosciences Details

2.2.2 Genocea Biosciences Major Business

2.2.3 Genocea Biosciences Neoantigen Targeted Therapies Product and Solutions

2.2.4 Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Genocea Biosciences Recent Developments and Future Plans

2.3 Gradalis

2.3.1 Gradalis Details

2.3.2 Gradalis Major Business

2.3.3 Gradalis Neoantigen Targeted Therapies Product and Solutions

2.3.4 Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Gradalis Recent Developments and Future Plans

2.4 Immunicum

2.4.1 Immunicum Details

2.4.2 Immunicum Major Business

2.4.3 Immunicum Neoantigen Targeted Therapies Product and Solutions

2.4.4 Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Immunicum Recent Developments and Future Plans

2.5 Immunovative Therapies

2.5.1 Immunovative Therapies Details

2.5.2 Immunovative Therapies Major Business

2.5.3 Immunovative Therapies Neoantigen Targeted Therapies Product and Solutions

2.5.4 Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Immunovative Therapies Recent Developments and Future Plans

2.6 Iovance Biotherapeutics

2.6.1 Iovance Biotherapeutics Details

2.6.2 Iovance Biotherapeutics Major Business

2.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Product and Solutions

2.6.4 Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Iovance Biotherapeutics Recent Developments and Future Plans

2.7 MediGene

2.7.1 MediGene Details

2.7.2 MediGene Major Business

2.7.3 MediGene Neoantigen Targeted Therapies Product and Solutions

2.7.4 MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 MediGene Recent Developments and Future Plans

2.8 Neon Therapeutics

2.8.1 Neon Therapeutics Details

2.8.2 Neon Therapeutics Major Business

2.8.3 Neon Therapeutics Neoantigen Targeted Therapies Product and Solutions

2.8.4 Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Neon Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Neoantigen Targeted Therapies Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Neoantigen Targeted Therapies Players Market Share in 2021

3.2.2 Top 10 Neoantigen Targeted Therapies Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Neoantigen Targeted Therapies Players Head Office, Products and Services Provided

3.4 Neoantigen Targeted Therapies Mergers & Acquisitions

3.5 Neoantigen Targeted Therapies New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Type (2017-2022)

4.2 Global Neoantigen Targeted Therapies Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Neoantigen Targeted Therapies Revenue Market Share by Application (2017-2022)

5.2 Global Neoantigen Targeted Therapies Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Neoantigen Targeted Therapies Revenue by Type (2017-2028)

6.2 North America Neoantigen Targeted Therapies Revenue by Application (2017-2028)

6.3 North America Neoantigen Targeted Therapies Market Size by Country

6.3.1 North America Neoantigen Targeted Therapies Revenue by Country (2017-2028)

6.3.2 United States Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

6.3.3 Canada Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

6.3.4 Mexico Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Neoantigen Targeted Therapies Revenue by Type (2017-2028)

7.2 Europe Neoantigen Targeted Therapies Revenue by Application (2017-2028)

7.3 Europe Neoantigen Targeted Therapies Market Size by Country

7.3.1 Europe Neoantigen Targeted Therapies Revenue by Country (2017-2028)

7.3.2 Germany Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

7.3.3 France Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

7.3.5 Russia Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

7.3.6 Italy Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Neoantigen Targeted Therapies Revenue by Type (2017-2028)

8.2 Asia-Pacific Neoantigen Targeted Therapies Revenue by Application (2017-2028)

8.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region

8.3.1 Asia-Pacific Neoantigen Targeted Therapies Revenue by Region (2017-2028)

8.3.2 China Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

8.3.3 Japan Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

8.3.4 South Korea Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

8.3.5 India Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

8.3.7 Australia Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Neoantigen Targeted Therapies Revenue by Type (2017-2028)

9.2 South America Neoantigen Targeted Therapies Revenue by Application (2017-2028)

9.3 South America Neoantigen Targeted Therapies Market Size by Country

9.3.1 South America Neoantigen Targeted Therapies Revenue by Country (2017-2028)

9.3.2 Brazil Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

9.3.3 Argentina Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Neoantigen Targeted Therapies Revenue by Type (2017-2028)

10.2 Middle East & Africa Neoantigen Targeted Therapies Revenue by Application (2017-2028)

10.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country

10.3.1 Middle East & Africa Neoantigen Targeted Therapies Revenue by Country (2017-2028)

10.3.2 Turkey Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

10.3.4 UAE Neoantigen Targeted Therapies Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Neoantigen Targeted Therapies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Neoantigen Targeted Therapies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Neoantigen Targeted Therapies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Neoantigen Targeted Therapies Revenue (USD Million) by Region (2017-2022)

Table 5. Global Neoantigen Targeted Therapies Revenue Market Share by Region (2023-2028)

Table 6. Bavarian Nordic Corporate Information, Head Office, and Major Competitors

Table 7. Bavarian Nordic Major Business

Table 8. Bavarian Nordic Neoantigen Targeted Therapies Product and Solutions

Table 9. Bavarian Nordic Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Genocea Biosciences Corporate Information, Head Office, and Major Competitors

Table 11. Genocea Biosciences Major Business

Table 12. Genocea Biosciences Neoantigen Targeted Therapies Product and Solutions

Table 13. Genocea Biosciences Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Gradalis Corporate Information, Head Office, and Major Competitors

Table 15. Gradalis Major Business

Table 16. Gradalis Neoantigen Targeted Therapies Product and Solutions

Table 17. Gradalis Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Immunicum Corporate Information, Head Office, and Major Competitors

Table 19. Immunicum Major Business

Table 20. Immunicum Neoantigen Targeted Therapies Product and Solutions

Table 21. Immunicum Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Immunovative Therapies Corporate Information, Head Office, and Major Competitors

Table 23. Immunovative Therapies Major Business

Table 24. Immunovative Therapies Neoantigen Targeted Therapies Product and Solutions

Table 25. Immunovative Therapies Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Iovance Biotherapeutics Corporate Information, Head Office, and Major Competitors

Table 27. Iovance Biotherapeutics Major Business

Table 28. Iovance Biotherapeutics Neoantigen Targeted Therapies Product and Solutions

Table 29. Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. MediGene Corporate Information, Head Office, and Major Competitors

Table 31. MediGene Major Business

Table 32. MediGene Neoantigen Targeted Therapies Product and Solutions

Table 33. MediGene Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Neon Therapeutics Corporate Information, Head Office, and Major Competitors

Table 35. Neon Therapeutics Major Business

Table 36. Neon Therapeutics Neoantigen Targeted Therapies Product and Solutions

Table 37. Neon Therapeutics Neoantigen Targeted Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Global Neoantigen Targeted Therapies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 39. Global Neoantigen Targeted Therapies Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 40. Breakdown of Neoantigen Targeted Therapies by Company Type (Tier 1, Tier 2 and Tier 3)

Table 41. Neoantigen Targeted Therapies Players Head Office, Products and Services Provided

Table 42. Neoantigen Targeted Therapies Mergers & Acquisitions in the Past Five Years

Table 43. Neoantigen Targeted Therapies New Entrants and Expansion Plans

Table 44. Global Neoantigen Targeted Therapies Revenue (USD Million) by Type (2017-2022)

Table 45. Global Neoantigen Targeted Therapies Revenue Share by Type (2017-2022)

Table 46. Global Neoantigen Targeted Therapies Revenue Forecast by Type (2023-2028)

Table 47. Global Neoantigen Targeted Therapies Revenue by Application (2017-2022)

Table 48. Global Neoantigen Targeted Therapies Revenue Forecast by Application (2023-2028)

Table 49. North America Neoantigen Targeted Therapies Revenue by Type (2017-2022) & (USD Million)

Table 50. North America Neoantigen Targeted Therapies Revenue by Type (2023-2028) & (USD Million)

Table 51. North America Neoantigen Targeted Therapies Revenue by Application (2017-2022) & (USD Million)

Table 52. North America Neoantigen Targeted Therapies Revenue by Application (2023-2028) & (USD Million)

Table 53. North America Neoantigen Targeted Therapies Revenue by Country (2017-2022) & (USD Million)

Table 54. North America Neoantigen Targeted Therapies Revenue by Country (2023-2028) & (USD Million)

Table 55. Europe Neoantigen Targeted Therapies Revenue by Type (2017-2022) & (USD Million)

Table 56. Europe Neoantigen Targeted Therapies Revenue by Type (2023-2028) & (USD Million)

Table 57. Europe Neoantigen Targeted Therapies Revenue by Application (2017-2022) & (USD Million)

Table 58. Europe Neoantigen Targeted Therapies Revenue by Application (2023-2028) & (USD Million)

Table 59. Europe Neoantigen Targeted Therapies Revenue by Country (2017-2022) & (USD Million)

Table 60. Europe Neoantigen Targeted Therapies Revenue by Country (2023-2028) & (USD Million)

Table 61. Asia-Pacific Neoantigen Targeted Therapies Revenue by Type (2017-2022) & (USD Million)

Table 62. Asia-Pacific Neoantigen Targeted Therapies Revenue by Type (2023-2028) & (USD Million)

Table 63. Asia-Pacific Neoantigen Targeted Therapies Revenue by Application (2017-2022) & (USD Million)

Table 64. Asia-Pacific Neoantigen Targeted Therapies Revenue by Application (2023-2028) & (USD Million)

Table 65. Asia-Pacific Neoantigen Targeted Therapies Revenue by Region (2017-2022) & (USD Million)

Table 66. Asia-Pacific Neoantigen Targeted Therapies Revenue by Region (2023-2028) & (USD Million)

Table 67. South America Neoantigen Targeted Therapies Revenue by Type (2017-2022) & (USD Million)

Table 68. South America Neoantigen Targeted Therapies Revenue by Type (2023-2028) & (USD Million)

Table 69. South America Neoantigen Targeted Therapies Revenue by Application (2017-2022) & (USD Million)

Table 70. South America Neoantigen Targeted Therapies Revenue by Application (2023-2028) & (USD Million)

Table 71. South America Neoantigen Targeted Therapies Revenue by Country (2017-2022) & (USD Million)

Table 72. South America Neoantigen Targeted Therapies Revenue by Country (2023-2028) & (USD Million)

Table 73. Middle East & Africa Neoantigen Targeted Therapies Revenue by Type (2017-2022) & (USD Million)

Table 74. Middle East & Africa Neoantigen Targeted Therapies Revenue by Type (2023-2028) & (USD Million)

Table 75. Middle East & Africa Neoantigen Targeted Therapies Revenue by Application (2017-2022) & (USD Million)

Table 76. Middle East & Africa Neoantigen Targeted Therapies Revenue by Application (2023-2028) & (USD Million)

Table 77. Middle East & Africa Neoantigen Targeted Therapies Revenue by Country (2017-2022) & (USD Million)

Table 78. Middle East & Africa Neoantigen Targeted Therapies Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Neoantigen Targeted Therapies Picture

Figure 2. Global Neoantigen Targeted Therapies Revenue Market Share by Type in 2021

Figure 3. Monotherapy

Figure 4. Combination Therapy

Figure 5. Neoantigen Targeted Therapies Revenue Market Share by Application in 2021

Figure 6. Medical Research Institution Picture

Figure 7. Hospital and Clinic Picture

Figure 8. Other Picture

Figure 9. Global Neoantigen Targeted Therapies Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Neoantigen Targeted Therapies Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Neoantigen Targeted Therapies Revenue Market Share by Region (2017-2028)

Figure 12. Global Neoantigen Targeted Therapies Revenue Market Share by Region in 2021

Figure 13. North America Neoantigen Targeted Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Neoantigen Targeted Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Neoantigen Targeted Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Neoantigen Targeted Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Neoantigen Targeted Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Neoantigen Targeted Therapies Market Drivers

Figure 19. Neoantigen Targeted Therapies Market Restraints

Figure 20. Neoantigen Targeted Therapies Market Trends

Figure 21. Bavarian Nordic Recent Developments and Future Plans

Figure 22. Genocea Biosciences Recent Developments and Future Plans

Figure 23. Gradalis Recent Developments and Future Plans

Figure 24. Immunicum Recent Developments and Future Plans

Figure 25. Immunovative Therapies Recent Developments and Future Plans

Figure 26. Iovance Biotherapeutics Recent Developments and Future Plans

Figure 27. MediGene Recent Developments and Future Plans

Figure 28. Neon Therapeutics Recent Developments and Future Plans

Figure 29. Global Neoantigen Targeted Therapies Revenue Share by Players in 2021

Figure 30. Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 31. Global Top 3 Players Neoantigen Targeted Therapies Revenue Market Share in 2021

Figure 32. Global Top 10 Players Neoantigen Targeted Therapies Revenue Market Share in 2021

Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 34. Global Neoantigen Targeted Therapies Revenue Share by Type in 2021

Figure 35. Global Neoantigen Targeted Therapies Market Share Forecast by Type (2023-2028)

Figure 36. Global Neoantigen Targeted Therapies Revenue Share by Application in 2021

Figure 37. Global Neoantigen Targeted Therapies Market Share Forecast by Application (2023-2028)

Figure 38. North America Neoantigen Targeted Therapies Sales Market Share by Type (2017-2028)

Figure 39. North America Neoantigen Targeted Therapies Sales Market Share by Application (2017-2028)

Figure 40. North America Neoantigen Targeted Therapies Revenue Market Share by Country (2017-2028)

Figure 41. United States Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Neoantigen Targeted Therapies Sales Market Share by Type (2017-2028)

Figure 45. Europe Neoantigen Targeted Therapies Sales Market Share by Application (2017-2028)

Figure 46. Europe Neoantigen Targeted Therapies Revenue Market Share by Country (2017-2028)

Figure 47. Germany Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. France Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. United Kingdom Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Russia Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Italy Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Asia-Pacific Neoantigen Targeted Therapies Sales Market Share by Type (2017-2028)

Figure 53. Asia-Pacific Neoantigen Targeted Therapies Sales Market Share by Application (2017-2028)

Figure 54. Asia-Pacific Neoantigen Targeted Therapies Revenue Market Share by Region (2017-2028)

Figure 55. China Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Japan Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. South Korea Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. India Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Southeast Asia Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Australia Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South America Neoantigen Targeted Therapies Sales Market Share by Type (2017-2028)

Figure 62. South America Neoantigen Targeted Therapies Sales Market Share by Application (2017-2028)

Figure 63. South America Neoantigen Targeted Therapies Revenue Market Share by Country (2017-2028)

Figure 64. Brazil Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Argentina Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Middle East and Africa Neoantigen Targeted Therapies Sales Market Share by Type (2017-2028)

Figure 67. Middle East and Africa Neoantigen Targeted Therapies Sales Market Share by Application (2017-2028)

Figure 68. Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Country (2017-2028)

Figure 69. Turkey Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Saudi Arabia Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. UAE Neoantigen Targeted Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Methodology

Figure 73. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz